We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aduro Biotech Inc | NASDAQ:ADRO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.595 | 14.60 | 17.00 | 0 | 01:00:00 |
CUSIP No. 16961L106
|
|
(1) Names of reporting persons Point72 Asset Management, L.P.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 3,047,732 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 3,047,732 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
3,047,732 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 5.0% (a) (see Item 4)
|
|
(12) Type of reporting person (see instructions) PN
|
CUSIP No. 16961L106
|
|
(1) Names of reporting persons Point72 Capital Advisors, Inc.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 3,047,732 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 3,047,732 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
3,047,732 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 5.0% (a) (see Item 4)
|
|
(12) Type of reporting person (see instructions) CO
|
CUSIP No. 16961L106
|
|
(1) Names of reporting persons Cubist Systematic Strategies, LLC
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 69,748 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 69,748 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
69,748 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0.1% (a) (see Item 4)
|
|
(12) Type of reporting person (see instructions) OO
|
CUSIP No. 16961L106
|
|
(1) Names of reporting persons Steven A. Cohen
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization United States
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 3,117,480 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 3,117,480 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
3,117,480 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 5.1% (a) (see Item 4)
|
|
(12) Type of reporting person (see instructions) IN
|
(a)
|
This calculation is based on 61,545,185 shares of Common Stock outstanding
as of May 27, 2022, as reported in the Issuer’s final prospectus supplement dated May 24, 2022, filed on May 25, 2022 with the Securities and Exchange Commission. |
1 Year Aduro Biotech Chart |
1 Month Aduro Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions